Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,312 | 442 | 89.6% |
| Consulting Fee | $1,520 | 1 | 10.2% |
| Education | $32.12 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $6,337 | 128 | $0 (2024) |
| Amarin Pharma Inc. | $1,580 | 63 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,172 | 38 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $960.09 | 48 | $0 (2024) |
| Novo Nordisk Inc | $571.14 | 18 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $501.24 | 12 | $0 (2019) |
| Lilly USA, LLC | $492.77 | 24 | $0 (2024) |
| Amgen Inc. | $281.13 | 13 | $0 (2024) |
| PFIZER INC. | $268.60 | 15 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $265.00 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,963 | 80 | Gilead Sciences, Inc. ($620.22) |
| 2023 | $1,782 | 66 | Gilead Sciences, Inc. ($749.91) |
| 2022 | $1,804 | 53 | Gilead Sciences, Inc. ($585.10) |
| 2021 | $889.96 | 35 | Amarin Pharma Inc. ($288.21) |
| 2020 | $637.69 | 28 | Gilead Sciences, Inc. ($305.86) |
| 2019 | $1,956 | 65 | Gilead Sciences, Inc. ($597.94) |
| 2018 | $3,657 | 64 | Gilead Sciences, Inc. ($2,414) |
| 2017 | $2,174 | 55 | Gilead Sciences Inc ($800.32) |
All Payment Transactions
446 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Cardio-renal | ||||||
| 12/12/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.94 | General |
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Respiratory | ||||||
| 11/28/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.22 | General |
| 11/13/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: DERMATOLOGY | ||||||
| 11/12/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: VACCINES | ||||||
| 11/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Cardio-renal | ||||||
| 11/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.92 | General |
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: DERMATOLOGY | ||||||
| 10/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.16 | General |
| 10/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Cardio-renal | ||||||
| 09/23/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.88 | General |
| 09/16/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Bone Health | ||||||
| 09/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: PAIN | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: RESPIRATORY | ||||||
| 09/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Cardio-renal | ||||||
| 08/27/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 404 | 745 | $92,541 | $43,026 |
| 2022 | 11 | 542 | 1,116 | $136,143 | $68,325 |
| 2021 | 16 | 660 | 1,229 | $147,965 | $71,339 |
| 2020 | 15 | 845 | 1,863 | $222,815 | $83,811 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 372 | $55,800 | $25,564 | 45.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 41 | 41 | $10,250 | $6,081 | 59.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 33 | 33 | $3,300 | $2,374 | 71.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 19 | 22 | $2,640 | $1,653 | 62.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 13 | $2,340 | $1,527 | 65.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 31 | 39 | $3,900 | $1,503 | 38.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 38 | 38 | $1,900 | $1,358 | 71.5% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 40 | 40 | $4,000 | $860.80 | 21.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 61 | 100 | $4,000 | $840.00 | 21.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 30 | 30 | $3,000 | $645.60 | 21.5% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 11 | 17 | $1,411 | $619.36 | 43.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 95 | 485 | $72,750 | $36,159 | 49.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 71 | 194 | $19,400 | $11,100 | 57.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 49 | 49 | $11,200 | $7,710 | 68.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 29 | $5,220 | $3,215 | 61.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 45 | 45 | $4,500 | $3,084 | 68.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $3,223 | $2,226 | 69.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 49 | 49 | $2,450 | $1,738 | 70.9% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 63 | 63 | $6,300 | $1,443 | 22.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 45 | 45 | $4,500 | $1,011 | 22.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 71 | 127 | $5,080 | $376.11 | 7.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 19 | 19 | $1,520 | $262.37 | 17.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 109 | 568 | $85,200 | $41,851 | 49.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 63 | 63 | $11,340 | $10,202 | 90.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 16 | 16 | $4,688 | $3,260 | 69.5% |
About Hua Ding
Hua Ding is a Internal Medicine healthcare provider based in Flushing, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669545166.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Hua Ding has received a total of $14,864 in payments from pharmaceutical and medical device companies, with $1,963 received in 2024. These payments were reported across 446 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($13,312).
As a Medicare-enrolled provider, Ding has provided services to 2,451 Medicare beneficiaries, totaling 4,953 services with total Medicare billing of $266,500. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Flushing, NY
- Active Since 11/15/2006
- Last Updated 03/26/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1669545166
Products in Payments
- Vemlidy (Drug) $3,381
- Vascepa (Drug) $1,607
- JARDIANCE (Drug) $835.01
- Rybelsus (Drug) $432.47
- FARXIGA (Drug) $428.94
- AIRSUPRA (Drug) $317.54
- XARELTO (Drug) $313.09
- INGREZZA (Drug) $265.00
- OFEV (Drug) $201.54
- INVOKANA (Drug) $188.15
- MOUNJARO (Drug) $170.99
- GILOTRIF (Drug) $141.19
- SHINGRIX (Biological) $140.71
- Ozempic (Drug) $138.67
- Livalo (Drug) $136.03
- Otezla (Drug) $134.62
- AUSTEDO (Drug) $125.00
- Licart (Drug) $125.00
- TAGRISSO (Drug) $125.00
- STEGLATRO (Drug) $123.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Flushing
Calvin Pan, M.d, M.D
Internal Medicine — Payments: $975,186
Ari Bunim, Md, MD
Internal Medicine — Payments: $361,039
Glenn Turett, M.d, M.D
Internal Medicine — Payments: $231,558
Weining Liang, Md, MD
Internal Medicine — Payments: $180,077
Dr. Yong Yu, M.d, M.D
Internal Medicine — Payments: $144,144
Dr. John Sciales, M.d, M.D
Internal Medicine — Payments: $92,715